MGRX — Mangoceuticals, Inc.
$0.2318-5.12%
Last close: · regular session
After-hours $0.2320 +0.09% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for MGRX in the TickerWise workspace.
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Company profile
- Sector: Healthcare
- Industry: Medical - Healthcare Information Services
- Country: US
- Exchange: NASDAQ Capital Market
- Employees: 3
- Website: https://www.mangoceuticals.com
Latest SEC filings for MGRX
Latest MGRX news
- Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session Read article
- Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.